Sound Pharmaceuticals Receives FDA Breakthrough Therapy Designation for SPI-1005 to Treat Meniere’s Disease
businesswire.com/news/home/20251201807651/en/...Posted Dec 1, 2025, 6:49 PM UTC
10
businesswire.com
Loading comments…
Posted Dec 1, 2025, 6:49 PM UTC